PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Real-world data indicated ART with DTG+3TC was effective and well tolerated among patients with HIV infection regardless of prior ART exposure.

The burden of babesiosis disease was significantly worse among patients with vs without immunocompromising conditions.

Highly pathogenic avian influenza viruses were found in 38 people in CA from Sept. 30 to Dec. 24, 2024, including the first pediatric case in the US.

The DOJ has accused CHEST and other medical journals of scientific bias, demanding responses to a list of questions by May 2, 2025.

Patients with AUD in the ICU exhibited high rates of infection, complications, morbidity, and in-hospital mortality.

As case numbers rise, public health officials are warning of yet another difficult year of battling pertussis infections.